5:23 PM
 | 
Oct 08, 2009
 |  BC Extra  |  Company News

FDA reports potential safety issues

FDA issued a new quarterly list of drugs it is reviewing for potential safety issues identified through the Adverse Events Reporting System (AERS). The new

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >